Athersys (ATHX) News Today Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Athersys (NASDAQ:ATHX) Now Covered by StockNews.comDecember 17, 2024 | americanbankingnews.comCritical Survey: Zentalis Pharmaceuticals (NASDAQ:ZNTL) & Athersys (NASDAQ:ATHX)December 16, 2024 | americanbankingnews.comAthersys, Inc. (ATHXQ)April 24, 2024 | finance.yahoo.comBankruptcy of once-promising Athersys winding down with assets saleApril 8, 2024 | bizjournals.comToughbuilt Industries Inc (TBLT)February 26, 2024 | investing.comAthersys Inc ATHXQFebruary 17, 2024 | morningstar.comAthersys to Sell Most Assets to HealiosJanuary 8, 2024 | marketwatch.comAthersys Reports Third Quarter 2023 Financial Results and Business HighlightsNovember 16, 2023 | finance.yahoo.comAthersys shares migrate to Pink marketplace for broker-to-broker tradingOctober 23, 2023 | bizjournals.comAthersys shares delisted by Nasdaq Stock MarketOctober 20, 2023 | bizjournals.comAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesOctober 16, 2023 | finance.yahoo.comAthersys crashes after bankruptcy warningOctober 10, 2023 | msn.comAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosOctober 10, 2023 | finance.yahoo.comTrading was temporarily halted for "ATHX" at 08:10 AM with a stated reason of "News pending."October 10, 2023 | marketbeat.comAthersys Licenses its Animal Health Assets to Ardent Animal HealthOctober 3, 2023 | businesswire.comAthersys Director Jane Wasman Appointed Board ChairOctober 2, 2023 | finance.yahoo.comAthersys Slumps as MultiStem Fails in Mid-Stage Study - Analyst BlogSeptember 26, 2023 | finance.yahoo.comGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationSeptember 6, 2023 | finance.yahoo.comIs Athersys Inc (ATHX) Significantly Overvalued?August 25, 2023 | finance.yahoo.comAthersys Shares Tumble 26% After Pricing Public OfferingAugust 18, 2023 | marketwatch.comWhy Is Athersys (ATHX) Stock Down 36% Today?August 18, 2023 | investorplace.comAthersys shares slide on pricing $3.5 million stock offeringAugust 18, 2023 | seekingalpha.comAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingAugust 18, 2023 | finance.yahoo.comAthersys Reports Second Quarter 2023 Financial Results and Business HighlightsAugust 16, 2023 | finance.yahoo.comAthersys Appoints Neema Mayhugh, PhD to its Board of DirectorsAugust 11, 2023 | finance.yahoo.comAthersys executives foresee catalysts that could ease its financial journeyAugust 11, 2023 | bizjournals.comAthersys to Host Business Update Conference Call on August 9thJuly 31, 2023 | businesswire.comAthersys (NASDAQ: ATHX)July 30, 2023 | fool.comPatient Enrollment Begins in Third and Final CohortJune 1, 2023 | tmcnet.comPatient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic TraumaJune 1, 2023 | finance.yahoo.comAthersys restructures debt with supplier, prioritizing multi-stem for stroke treatmentMay 23, 2023 | msn.comAthersys Restructures Debt with SupplierMay 23, 2023 | finance.yahoo.comAthersys cuts quarterly loss as restructuring takes holdMay 18, 2023 | bizjournals.comAthersys Reports First Quarter 2023 Financial Results and Business HighlightsMay 18, 2023 | finance.yahoo.comAthersys to Participate in Three Upcoming ConferencesMay 8, 2023 | finance.yahoo.comAthersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care ConferenceMay 1, 2023 | finance.yahoo.comAthersys to Participate in The American Society for Neural Therapy and Repair Annual ConferenceApril 21, 2023 | finance.yahoo.comAthersys, Inc. Announces Closing of $3.7 Million Registered Direct Offering and Concurrent Private PlacementApril 19, 2023 | finance.yahoo.comAthersys, Inc. Announces $3.7 Million Registered Direct Offering and Concurrent Private PlacementApril 18, 2023 | finance.yahoo.comAthersys to Host Business Update Conference Call on April 20 thApril 12, 2023 | businesswire.comAthersys to Host Business Update Conference Call on April 20thApril 10, 2023 | finance.yahoo.comAthersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 31, 2023 | finance.yahoo.comAthersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 31, 2023 | finance.yahoo.comAthersys Announces Successful Type B Meeting with the FDAMarch 22, 2023 | finance.yahoo.comAthersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol DiscussionFebruary 14, 2023 | finance.yahoo.comAthersys to Host Business Update Conference Call on February 14thFebruary 2, 2023 | finance.yahoo.comAthersys to Participate in International Stroke Conference and BioProcess InternationalJanuary 30, 2023 | finance.yahoo.comAthersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in JanuaryJanuary 11, 2023 | finance.yahoo.comAthersys Provides MultiStem Clinical UpdateJanuary 9, 2023 | finance.yahoo.comAthersys (ATHX) Stock Plummets to 52-Week Low as Stroke Therapy Fails Mid-Stage TrialJanuary 4, 2023 | thestreet.com Get Athersys News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter. Email Address This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW ATHX Media Mentions By Week ATHX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATHX News Sentiment▼0.000.59▲Average Medical News Sentiment ATHX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATHX Articles This Week▼20▲ATHX Articles Average Week Get Athersys News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NuCana News Today Sunshine Biopharma News Today China Pharma News Today Tharimmune News Today Quoin Pharmaceuticals News Today Lipella Pharmaceuticals News Today Qualigen Therapeutics News Today Phio Pharmaceuticals News Today Aravive News Today Alaunos Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATHX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athersys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athersys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
